About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
Targeted Oncology7h
Best Practices and Strategies for Luspatercept in the Treatment of LR-MDS
Thomas W. LeBlanc, MD, MA, discusses key clinical pearls for community oncologists in the treatment of anemia in patients with low-risk myelodysplastic syndromes (LR-MDS), including the importance of ...
Frontiers9h
Decoding the Spectrum of Plasma Cell Heterogeneity: Insights into Maturity and Longevity
Plasma cells (PCs) are the terminal differentiation stage of activated B cells and serve as crucial effector cells in humoral immunity. While PCs have ...
Medscape1d
Is One Cycle of Neoadjuvant Pembro Enough in dMMR Colon Cancer?
About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
The Lancet1d
Corticosteroids in community-acquired pneumonia: a step forward, but questions remain
Community-acquired pneumonia (CAP) is a systemic disease and continues to be the leading cause of infectious mortality ...